Pharm Genesis
A merger creating a new kid on the block, NEXT GENeSYS Corp., hopes to capitalize on an $8 billion-plus healthcare and prescription drug market.
The merger will bring together four companies, specializing in RFID, online pharmaceuticals, and other wireless technologies. Announced in August, the merger isn’t complete yet and there has been no indication when it will be.
There are 899 words in the rest of this article …
Library Access Required
Library subscribers have access to the full archives of more than 10,000 original news items and feature articles published by AVISIAN’s suite of ID technology publications (ContactlessNews.com, CR80News.com, DigitalIDNews.com, FIPS201.com, NFCNews.com, RFIDNews.org, SecureIDNews.com, and ThirdFactor.com).
For just $99, you receive unlimited password-protected access to content on all of AVISIAN’s sites for an entire year. Your subscription helps fund the continued creation of independent, insightful content. Find out more.
Sign in as a Subscriber
If you are already a subscriber, you may sign in now. Enter your Email Address and Password and click Sign In.
If you have forgotten your password, enter just your Email Address, and click Send Password.
